J0570 Insurance Policy Changes

HCPCS J0570 is officially defined as "Buprenorphine implant, 74.2 mg." HCPCS J0570 is referenced in 5 tracked payer policy changes from Sentara Health Plans, Blue Cross Blue Shield of Rhode Island, and 3 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0570 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.